Structures of human proteinase 3 and neutrophil elastase - So similar yet so different

FEBS Journal

Volumn 277, Issue 10, 2010, Pages 2238-2254

  Hajjar, Eric ^a   Broemstrup, Torben ^b   Kantari, Chahrazade ^c   Witko Sarsat, Véronique ^c,d   Reuter, Nathalie ^b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF BERGEN   (Norway)

^c INSERM   (France)

^d INSTITUT COCHIN   (France)

Author keywords

Human neutrophil elastase; Inflammation; Myeloblastin; Neutrophil; Proteinase 3; Vasculitis; Wegener granulomatosis

Indexed keywords

AUTOANTIBODY; LEUKOCYTE ELASTASE; MEMBRANE PROTEIN; MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

BINDING SITE; CELL MEMBRANE; COMPUTER MODEL; ENZYME ACTIVITY; ENZYME GLYCOSYLATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; HUMAN; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SPECIES DIFFERENCE; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; SURFACE PROPERTY; X RAY CRYSTALLOGRAPHY;

ANIMALS; HUMANS; LEUKOCYTE ELASTASE; MYELOBLASTIN; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY;

ANIMALIA; MURINAE;

EID: 77951745688     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07659.x     Document Type: Review

References (106)

1. Bories D, Raynal MC, Solomon DH, Darzynkiewicz Z Cayre YE (1989) Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells. Cell 59, 959 968.
2. Campanelli D, Detmers PA, Nathan CF Gabay JE (1990) Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties. J Clin Invest 85, 904 915.
3. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P Halbwachs-Mecarelli L (2000) Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 80, 617 653.
4. Nathan C (2006) Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6, 173 182.
5. Belaaouaj A, Kim KS Shapiro SD (2000) Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase. Science 289, 1185 1188.
6. + flux. Nature 416, 291 297.
7. Wiedow O Meyer-Hoffert U (2005) Neutrophil serine proteases: potential key regulators of cell signalling during inflammation. J Intern Med 257, 319 328.
8. Pham CT (2006) Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol 6, 541 550.
9. Witko-Sarsat V, Daniel S, Noel LH Mouthon L (2009) Neutrophils and B lymphocytes in ANCA-associated vasculitis. APMIS Suppl 117, 27 31.
10. Hajjar E, Korkmaz B, Gauthier F, Brandsdal BO, Witko-Sarsat V Reuter N (2006) Inspection of the binding sites of proteinase3 for the design of a highly specific substrate. J Med Chem 49, 1248 1260.
11. Hajjar E, Korkmaz B Reuter N (2007) Differences in the substrate binding sites of murine and human proteinase 3 and neutrophil elastase. FEBS Lett 581, 5685 5690.
12. Korkmaz B, Hajjar E, Kalupov T, Reuter N, Brillard-Bourdet M, Moreau T, Juliano L Gauthier F (2007) Influence of charge distribution at the active site surface on the substrate specificity of human neutrophil protease 3 and elastase. A kinetic and molecular modeling analysis. J Biol Chem 282, 1989 1997.
13. Hajjar E, Mihajlovic M, Witko-Sarsat V, Lazaridis T Reuter N (2008) Computational prediction of the binding site of proteinase 3 to the plasma membrane. Proteins 71, 1655 1669.
14. Kalupov T, Brillard-Bourdet M, Dade S, Serrano H, Wartelle J, Guyot N, Juliano L, Moreau T, Belaaouaj A Gauthier F (2009) Structural characterization of mouse neutrophil serine proteases and identification of their substrate specificities: relevance to mouse models of human inflammatory diseases. J Biol Chem 284, 34084 34091.
15. Rawlings ND, Morton FR, Kok CY, Kong J Barrett AJ (2008) MEROPS: the peptidase database. Nucleic Acids Res 36, D320 D325.
16. Schechter I Berger A (1967) On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 27, 157 162.
17. Takahashi H, Nukiwa T, Yoshimura K, Quick CD, States DJ, Holmes MD, Whang-Peng J, Knutsen T Crystal RG (1988) Structure of the human neutrophil elastase gene. J Biol Chem 263, 14739 14747.
18. Sinha S, Watorek W, Karr S, Giles J, Bode W Travis J (1987) Primary structure of human neutrophil elastase. Proc Natl Acad Sci USA 84, 2228 2232.
19. Okano K, Aoki Y, Sakurai T, Kajitani M, Kanai S, Shimazu T, Shimizu H Naruto M (1987) Molecular cloning of complementary DNA for human medullasin: an inflammatory serine protease in bone marrow cells. J Biochem 102, 13 16.
20. Nakamura H, Okano K, Aoki Y, Shimizu H Naruto M (1987) Nucleotide sequence of human bone marrow serine protease (medullasin) gene. Nucleic Acids Res 15, 9601 9602.
21. Jenne DE, Tschopp J, Ludemann J, Utecht B Gross WL (1990) Wegener's autoantigen decoded. Nature 346, 520.
22. Campanelli D, Melchior M, Fu Y, Nakata M, Shuman H, Nathan C Gabay JE (1990) Cloning of cDNA for proteinase 3: a serine protease, antibiotic, and autoantigen from human neutrophils. J Exp Med 172, 1709 1715.
23. Sturrock A, Franklin K, Rao G, Marshall B, Rebentisch M, Lemons R Hoidal J (1992) Structure, chromosomal assignment, and expression of the gene for proteinase-3. The Wegener's granulomatosis autoantigen. J Biol Chem 267, 21193 21199.
24. Lindmark A, Persson AM Olsson I (1990) Biosynthesis and processing of cathepsin G and neutrophil elastase in the leukemic myeloid cell line U-937. Blood 76, 2374 2380.
25. Rao NV, Rao GV, Marshall BC Hoidal JR (1996) Biosynthesis and processing of proteinase 3 in U937 cells. Processing pathways are distinct from those of cathepsin G. J Biol Chem 271, 2972 2978.
26. Garwicz D, Lindmark A, Hellmark T, Gladh M, Jogi J Gullberg U (1997) Characterization of the processing and granular targeting of human proteinase 3 after transfection to the rat RBL or the murine 32D leukemic cell lines. J Leukoc Biol 61, 113 123.
27. Gullberg U, Bengtsson N, Bulow E, Garwicz D, Lindmark A Olsson I (1999) Processing and targeting of granule proteins in human neutrophils. J Immunol Methods 232, 201 210.
28. van der Geld YM, Limburg PC Kallenberg CG (2001) proteinase 3, Wegener's autoantigen: from gene to antigen. J Leukoc Biol 69, 177 190.
29. Cregge R, Durham S, Farr R, Gallion S, Hare C, Hoffman R, Janusz M, Kim H, Koehl J, Mehdi S et al. (1998) Inhibition of human neutrophil elastase. 4. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of P2-modified, orally active peptidyl pentafluoroethyl ketones. J Med Chem 41, 2461 2480.
30. Macdonald SJF, Dowle MD, Harrison LA, Clarke GDE, Inglis GGA, Johnson MR, Shah P, Smith RA, Amour A, Fleetwood G et al. (2002) Discovery of further pyrrolidine trans-lactams as inhibitors of human neutrophil elastase (HNE) with potential as development candidates and the crystal structure of HNE complexed with an inhibitor (GW475151). J Med Chem 45, 3878 3890.
31. Navia M, McKeever B, Springer J, Lin T, Williams H, Fluder E, Dorn C Hoogsteen K (1989) Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84Å resolution. Proc Natl Acad Sci USA 86, 7 11.
32. Bode W, Wei A, Huber R, Meyer E, Travis J Neumann S (1986) X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor. EMBO J 5, 2453 2458.
33. Wei AZ, Mayr I Bode W (1988) The refined 2.3 A crystal structure of human leukocyte elastase in a complex with a valine chloromethyl ketone inhibitor. FEBS Lett 234, 367 373.
34. Huang W, Yamamoto Y, Li Y, Dou D, Alliston KR, Hanzlik RP, Williams TD Groutas WC (2008) X-ray snapshot of the mechanism of inactivation of human neutrophil elastase by 1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives. J Med Chem 51, 2003 2008.
35. Koizumi M, Fujino A, Fukushima K, Kamimura T Takimoto-Kamimura M (2008) Complex of human neutrophil elastase with 1/2SLPI. J Synchrotron Radiat 15, 308 311.
36. Fujinaga M, Chernaia MM, Halenbeck R, Koths K James MN (1996) The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies. J Mol Biol 261, 267 278.
37. Russell RB Barton GJ (1992) Multiple protein sequence alignment from tertiary structure comparison: assignment of global and residue confidence levels. Proteins 14, 309 323.
38. Specks U, Fass DN, Finkielman JD, Hummel AM, Viss MA, Litwiller RD McDonald CJ (2007) Functional significance of Asn-linked glycosylation of proteinase 3 for enzymatic activity, processing, targeting, and recognition by anti-neutrophil cytoplasmic antibodies. J Biochem 141, 101 112.
39. Hink-Schauer C, Estebanez-Perpina E, Wilharm E, Fuentes-Prior P, Klinkert W, Bode W Jenne DE (2002) The 2.2-A crystal structure of human pro-granzyme K reveals a rigid zymogen with unusual features. J Biol Chem 277, 50923 50933.
40. Wang D, Bode W Huber R (1985) Bovine chymotrypsinogen A X-ray crystal structure analysis and refinement of a new crystal form at 1.8 A resolution. J Mol Biol 185, 595 624.
41. Walter J, Steigemann W, Singh TP, Bartunik H, Bode W Huber R (1982) On the disordered activation domain in trypsinogen - chemical labeling and low-temperature crystallography. Acta Crystallogr B 38, 1462 1472.
42. Campbell EJ, Campbell MA Owen CA (2000) Bioactive proteinase 3 on the cell surface of human neutrophils: quantification, catalytic activity, and susceptibility to inhibition. J Immunol 165, 3366 3374.
43. Hajjar E, Dejaegere A Reuter N (2009) Challenges in pK(a) predictions for proteins: the case of Asp213 in human proteinase 3. J Phys Chem 113, 11783 11792.
44. Dalton AK, Ako-Adjei D, Murray PS, Murray D Vogt VM (2007) Electrostatic interactions drive membrane association of the HIV-1 Gag MA domain. J Virol 81, 6434 6445.
45. Arbuzova A, Wang L, Wang J, Hangyas-Mihalyne G, Murray D, Honig B McLaughlin S (2000) Membrane binding of peptides containing both basic and aromatic residues. Experimental studies with peptides corresponding to the scaffolding region of caveolin and the effector region of MARCKS. Biochemistry 39, 10330 10339.
46. Mulgrew-Nesbitt A, Diraviyam K, Wang J, Singh S, Murray P, Li Z, Rogers L, Mirkovic N Murray D (2006) The role of electrostatics in protein-membrane interactions. Biochim Biophys Acta 1761, 812 826.
47. Powers JC, Gupton BF, Harley AD, Nishino N Whitley RJ (1977) Specificity of porcine pancreatic elastase, human leukocyte elastase and cathepsin G. Inhibition with peptide chloromethyl ketones. Biochim Biophys Acta 485, 156 166.
48. Zimmerman M Ashe BM (1977) Substrate specificity of the elastase and the chymotrypsin-like enzyme of the human granulocyte. Biochim Biophys Acta 480, 241 245.
49. Lestienne P Bieth JG (1980) Activation of human leukocyte elastase activity by excess substrate, hydrophobic solvents, and ionic strength. J Biol Chem 255, 9289 9294.
50. McRae B, Nakajima K, Travis J Powers JC (1980) Studies on reactivity of human leukocyte elastase, cathepsin G, and porcine pancreatic elastase toward peptides including sequences related to the reactive site of alpha 1-protease inhibitor (alpha 1-antitrypsin). Biochemistry 19, 3973 3978.
51. Harper JW, Cook RR, Roberts CJ, McLaughlin BJ Powers JC (1984) Active site mapping of the serine proteases human leukocyte elastase, cathepsin G, porcine pancreatic elastase, rat mast cell proteases I and II. Bovine chymotrypsin A alpha, and Staphylococcus aureus protease V-8 using tripeptide thiobenzyl ester substrates. Biochemistry 23, 2995 3002.
52. Stein RL, Strimpler AM, Hori H Powers JC (1987) Catalysis by human leukocyte elastase: mechanistic insights into specificity requirements. Biochemistry 26, 1301 1305. (Pubitemid 17045860)
53. Bode W, Meyer E Jr. Powers JC (1989) Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity, and mechanism-based inhibitors. Biochemistry 28, 1951 1963.
54. Koehl C, Knight G Bieth J (2003) Compared action of neutrophil proteinase 3 and elastase on model substrates. Favorable effect of S'-P' interactions on proteinase 3 catalysts. J Biol Chem 278, 12609 12612.
55. Rao NV, Wehner NG, Marshall BC, Gray WR, Gray BH Hoidal JR (1991) Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J Biol Chem 266, 9540 9548.
56. Brubaker MJ, Groutas WC, Hoidal JR Rao NV (1992) Human neutrophil proteinase 3: mapping of the substrate binding site using peptidyl thiobenzyl esters. Biochem Biophys Res Commun 188, 1318 1324.
57. Kam CM, Kerrigan JE, Dolman KM, Goldschmeding R, Von dem Borne AE Powers JC (1992) Substrate and inhibitor studies on proteinase 3. FEBS Lett 297, 119 123.
58. Korkmaz B, Attucci S, Hazouard E, Ferrandiere M, Jourdan ML, Brillard-Bourdet M, Juliano L Gauthier F (2002) Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substrates. J Biol Chem 277, 39074 39081.
59. Li Y, Yang Q, Dou D, Alliston KR Groutas WC (2008) Inactivation of human neutrophil elastase by 1,2,5-thiadiazolidin-3-one 1,1 dioxide-based sulfonamides. Bioorg Med Chem 16, 692 698.
60. Hedstrom L (2002) Serine protease mechanism and specificity. Chem Rev 102, 4501 4524.
61. Hansson T, Oostenbrink C van Gunsteren W (2002) Molecular dynamics simulations. Curr Opin Struct Biol 12, 190 196.
62. Karplus M McCammon JA (2002) Molecular dynamics simulations of biomolecules. Nat Struct Biol 9, 646 652.
63. Adcock SA McCammon JA (2006) Molecular dynamics: survey of methods for simulating the activity of proteins. Chem Rev 106, 1589 1615.
64. Dublet B, Ruello A, Pederzoli M, Hajjar E, Courbebaisse M, Canteloup S, Reuter N Witko-Sarsat V (2005) Cleavage of p21/WAF1/CIP1 by proteinase 3 modulates differentiation of a monocytic cell line: molecular analysis of the cleavage site. J Biol Chem 280, 30242 30253.
65. Halbwachs-Mecarelli L, Bessou G, Lesavre P, Lopez S Witko-Sarsat V (1995) Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool. FEBS Lett 374, 29 33.
66. Schreiber A, Busjahn A, Luft FC Kettritz R (2003) Membrane expression of proteinase 3 is genetically determined. J Am Soc Nephrol 14, 68 75.
67. Witko-Sarsat V, Cramer EM, Hieblot C, Guichard J, Nusbaum P, Lopez S, Lesavre P Halbwachs-Mecarelli L (1999) Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules. Blood 94, 2487 2496.
68. Hu N, Westra J Kallenberg CG (2009) Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's granulomatosis. Autoimmun Rev 8, 510 514.
69. Witko-Sarsat V, Reuter N Mouthon L (2010) Interaction of proteinase 3 with its associated partners: implications in the pathogenesis of Wegener's granulomatosis. Curr Opin Rheumatol 22, 1 7.
70. David A, Kacher Y, Specks U Aviram I (2003) Interaction of proteinase 3 with CD11b/CD18 (beta2 integrin) on the cell membrane of human neutrophils. J Leukoc Biol 74, 551 557.
71. David A, Fridlich R Aviram I (2005) The presence of membrane proteinase 3 in neutrophil lipid rafts and its colocalization with FcgammaRIIIb and cytochrome b558. Exp Cell Res 308, 156 165.
72. Fridlich R, David A Aviram I (2006) Membrane proteinase 3 and its interactions within microdomains of neutrophil membranes. J Cell Biochem 99, 117 125.
73. Bauer S, Abdgawad M, Gunnarsson L, Segelmark M, Tapper H Hellmark T (2007) Proteinase 3 and CD177 are expressed on the plasma membrane of the same subset of neutrophils. J Leukoc Biol 81, 458 464.
74. von Vietinghoff S, Tunnemann G, Eulenberg C, Wellner M, Cardoso MC, Luft FC Kettritz R (2007) NB1 mediates surface expression of the ANCA antigen proteinase 3 on human neutrophils. Blood 109, 4487 4493.
75. Durant S, Pederzoli M, Lepelletier Y, Canteloup S, Nusbaum P, Lesavre P Witko-Sarsat V (2004) Apoptosis-induced proteinase 3 membrane expression is independent from degranulation. J Leukoc Biol 75, 87 98.
76. Kantari C, Pederzoli-Ribeil M, Amir-Moazami O, Gausson-Dorey V, Moura IC, Lecomte MC, Benhamou M Witko-Sarsat V (2007) Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis. Blood 110, 4086 4095.
77. Goldmann WH, Niles JL Arnaout MA (1999) Interaction of purified human proteinase 3 (PR3) with reconstituted lipid bilayers. Eur J Biochem 261, 155 162.
78. Korkmaz B, Jaillet J, Jourdan ML, Gauthier A, Gauthier F Attucci S (2009) Catalytic activity and inhibition of wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils. J Biol Chem 284, 19896 19902.
79. Stahelin RV, Ananthanarayanan B, Blatner NR, Singh S, Bruzik KS, Murray D Cho W (2004) Mechanism of membrane binding of the phospholipase D1 PX domain. J Biol Chem 279, 54918 54926.
80. McLaughlin S Murray D (2005) Plasma membrane phosphoinositide organization by protein electrostatics. Nature 438, 605 611.
81. Dalton AK, Murray PS, Murray D Vogt VM (2005) Biochemical characterization of rous sarcoma virus MA protein interaction with membranes. J Virol 79, 6227 6238.
82. Wijewickrama GT, Albanese A, Kim YJ, Oh YS, Murray PS, Takayanagi R, Tobe T, Masuda S, Murakami M, Kudo I et al. (2006) Unique membrane interaction mode of group IIF phospholipase A2. J Biol Chem 281, 32741 32754.
83. Sammalkorpi M Lazaridis T (2007) Modeling a spin-labeled fusion peptide in a membrane: implications for the interpretation of EPR experiments. Biophys J 92, 10 22.
84. Sammalkorpi M Lazaridis T (2007) Configuration of influenza hemagglutinin fusion peptide monomers and oligomers in membranes. Biochim Biophys Acta 1768, 30 38.
85. Jaud SE (2007) Self-induced docking site of a deeply embedded peripheral membrane protein. Biophys J 92, 517 524.
86. Daouk GH, Palsson R Arnaout MA (1995) Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis. Kidney Int 47, 1528 1536.
87. Preston GA Falk RJ (2001) ANCA signaling: not just a matter of respiratory burst. Kidney Int 59, 1981 1982.
88. Rarok AA, van der Geld YM, Stegeman CA, Limburg PC Kallenberg CG (2003) Diversity of PR3-ANCA epitope specificity in Wegener's granulomatosis. Analysis using the biosensor technology. J Clin Immunol 23, 460 468.
89. Abdel-Salam B, Iking-Konert C, Schneider M, Andrassy K Hansch GM (2004) Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood. Kidney Int 66, 1009 1017.
90. Van Rossum AP, van der Geld YM, Limburg PC Kallenberg CG (2005) Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils. Kidney Int 68, 537 541.
91. Bini P, Gabay JE, Teitel A, Melchior M, Zhou JL Elkon KB (1992) Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3. J Immunol 149, 1409 1415.
92. Williams RC Jr., Staud R, Malone CC, Payabyab J, Byres L Underwood D (1994) Epitopes on proteinase-3 recognized by antibodies from patients with Wegener's granulomatosis. J Immunol 152, 4722 4737.
93. Chang L, Binos S Savige J (1995) Epitope mapping of anti- proteinase 3 and anti-myeloperoxidase antibodies. Clin Exp Immunol 102, 112 119.
94. Van Der Geld YM, Limburg PC Kallenberg CG (1999) Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies. Clin Exp Immunol 118, 487 496.
95. Van der Geld YM, Simpelaar A, Van Der Zee R, Tervaert JW, Stegeman CA, Limburg PC Kallenberg CG (2001) Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides. Kidney Int 59, 147 159.
96. Selga D, Segelmark M, Wieslander J, Gunnarsson L Hellmark T (2004) Epitope mapping of anti-PR3 antibodies using chimeric human/mouse PR3 recombinant proteins. Clin Exp Immunol 135, 164 172.
97. Muller A, Voswinkel J, Gottschlich S Csernok E (2007) Human proteinase 3 (PR3) and its binding molecules: implications for inflammatory and PR3-related autoimmune responses. Ann NY Acad Sci 1109, 84 92.
98. van der Geld YM, Stegeman CA Kallenberg CG (2004) B cell epitope specificity in ANCA-associated vasculitis: does it matter? Clin Exp Immunol 137, 451 459.
99. Griffith ME, Coulthart A, Pemberton S, George AJ Pusey CD (2001) Anti-neutrophil cytoplasmic antibodies (ANCA) from patients with systemic vasculitis recognize restricted epitopes of proteinase 3 involving the catalytic site. Clin Exp Immunol 123, 170 177.
100. Wiesner O, Litwiller RD, Hummel AM, Viss MA, McDonald CJ, Jenne DE, Fass DN Specks U (2005) Differences between human proteinase 3 and neutrophil elastase and their murine homologues are relevant for murine model experiments. FEBS Lett 579, 5305 5312.
101. Pham CT (2008) Neutrophil serine proteases fine-tune the inflammatory response. Int J Biochem Cell Biol 40, 1317 1333.
102. Krem MM, Rose T Di Cera E (1999) The C-terminal sequence encodes function in serine proteases. J Biol Chem 274, 28063 28066.
103. Krem MM, Rose T Di Cera E (2000) Sequence determinants of function and evolution in serine proteases. Trends Cardiovasc Med 10, 171 176.
104. Witko-Sarsat V, Canteloup S, Durant S, Desdouets C, Chabernaud R, Lemarchand P Descamps-Latscha B (2002) Cleavage of p21waf1 by proteinase-3, a myeloid-specific serine protease, potentiates cell proliferation. J Biol Chem 277, 47338 47347.
105. Pederzoli M, Kantari C, Gausson V, Moriceau S Witko-Sarsat V (2005) Proteinase-3 induces procaspase-3 activation in the absence of apoptosis: potential role of this compartmentalized activation of membrane-associated procaspase-3 in neutrophils. J Immunol 174, 6381 6390.
106. Korkmaz B, Kuhl A, Bayat B, Santoso S Jenne DE (2008) A hydrophobic patch on proteinase 3, the target of autoantibodies in Wegener granulomatosis, mediates membrane binding via NB1 receptors. J Biol Chem 283, 35976 35982.